Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics

Rheumatoid arthritis (RA) is a chronic inflammatory disease that is very complex and heterogeneous. If not adequately treated, RA patients are likely to manifest excess of morbidity and disability with an important impact on the quality of life. Pharmacological treatment is based on the administrati...

Full description

Bibliographic Details
Main Authors: Valeria Conti, Graziamaria Corbi, Maria Costantino, Emanuela De Bellis, Valentina Manzo, Carmine Sellitto, Berenice Stefanelli, Francesca Colucci, Amelia Filippelli
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Biomolecules
Subjects:
autoimmune disorder
pharmacogenetics
methotrexate
disease-modifying antirheumatic drugs
autoantibodies
Online Access:https://www.mdpi.com/2218-273X/10/12/1672

Internet

https://www.mdpi.com/2218-273X/10/12/1672

Similar Items